Several studies have demonstrated that women with PCOS who use GLP-1 receptor agonists experience greater improvements in menstrual regularity and ovulation rates compared to those relying on lifestyle changes alone
Takagi D, Miyagi A, Tazoe Y et al (2020) Phosphorus toxicity disrupts Rubisco activation and reactive oxygen species defence systems by phytic acid accumulation in leaves
Researchers should choose KLOW when their protocol requires melanocortin anti-inflammatory signaling, NF-kappaB suppression, gut mucosal targeting through KPVs PepT1 transporter uptake, or a comparison arm against GLOW to isolate KPVs contribution to inflammatory resolution outcomes
Based on the above pharmacological characteristics of categories of GLP-1RAs agents, despite slight adverse gastrointestinal side effects, it is clear that GLP-1RAs agents have efficacy in cardiovascular protection without untoward hypoglycemia
Anything that concerns you warrants a call to your doctor